| Symbol | IMCC |
|---|---|
| Name | IM CANNABIS CORP. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medicinal Chemicals and Botanical Products |
| Address | CENTRAL DISTRICT, KIBBUTZ GLIL YAM, 4690500, Israel |
| Telephone | +972 544331111 |
| Fax | — |
| — | |
| Website | https://www.imcannabis.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001792030 |
| Description | IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Additional info from NASDAQ: |
IM Cannabis Corp. Announces First Quarter 2026 Financial Results USA - English …
Read moreIM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings
Read moreIM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings USA - English …
Read moreNASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.
Read moreNASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.
Read moreIMC Announces Receipt of Nasdaq Minimum Bid Price Notification USA - English …
Read more